The NYT fact checks RFK Jr: “Other than the U.S. version containing cyanide and arsenic, and still-wet rat turds, the Canadian and U.S. products are identical”
/Spitting out my coffee after reading this NYT "fact check" of RFK Jr. pic.twitter.com/sqL9jaeUR1
— Brad Cohn (@BradCohn) November 17, 2024
"Mr. Kennedy has singled out Froot Loops as an example of a product with too many artificial ingredients, questioning why the Canadian version has fewer than the U.S. version," the Times' report read. "But he was wrong. The ingredient list is roughly the same, although Canada’s has natural colorings made from blueberries and carrots while the U.S. product contains red dye 40, yellow 5 and blue 1 as well as Butylated hydroxytoluene, or BHT, a lab-made chemical that is used 'for freshness,' according to the ingredient label."
My personal opinion of RFK is that he’s a fruit loop himself, and his campaign against childhood vaccines is nuts, but I am enjoying the consternation and panic the threat of his appointment is causing the professional grifters in the Capital;This, from Politico:
Washington’s lobbyists are stunned Trump chose RFK Jr.
They’re holding their fire and hoping Senate allies will block his confirmation as HHS secretary.
Lobbyists expecting a more conventional pick to lead the government’s $3 trillion health agency than Robert F. Kennedy Jr., the brash contrarian President-elect Donald Trump named on Thursday to take charge, are plotting how to stop the Senate from confirming him.
They’re also currying favor in case they can’t.
Kennedy has proposed tighter regulation of the pesticides farmers use to juice their yields, a reexamination of vaccine safety data, a ban on highly processed foods in schools and a remaking of the agencies making the rules around health and food.
That could pose a major threat to a broad swath of American industry’s bottom line. Lobbyists who hadn’t taken the possibility seriously say their phones are blowing up over Trump’s decision, and industry leaders are trying to quickly leverage any connections to Kennedy to mitigate the risk he could pose. More than a dozen who work for companies in RFK’s crosshairs said they’re telling clients to keep their cool. Their attitude is indicative of the confusion gripping Washington’s lobbying corridor, K Street, since Trump’s election earlier this month.
Companies don’t want to start off on the wrong foot with Kennedy by coming out “in an extremely adversarial posture,” said John Strom, special counsel at the law firm Foley and Lardner who advises health industry leaders on policy issues.
“It’s prudent to take a wait and see approach,” he said, echoing lobbyists working across health and food sectors.
One health industry leader, granted anonymity to speak candidly about the appointment, acknowledged they were caught off guard — they had thought Trump would pick former Louisiana Gov. Bobby Jindal or former Surgeon General Jerome Adams — and hadn’t had any strategic conversations about opposing Kennedy.
“I knew he’d be part of the administration but thought it would be in a new role outside of the Cabinet,” the industry leader said. “We need to strengthen the CDC, and the public health infrastructure, not dismantle it as RFK has suggested.”
…. Companies would prefer to let their allies in the Senate, buttressed by years of campaign contributions and revolving-door hires, sideline Kennedy before they spend political capital to fight him.
If senators bow to Trump’s wishes instead and confirm Kennedy to lead HHS and its agencies, with their immense power over drugs, health insurance, Medicare and Medicaid spending and food safety, among other things, lobbyists don’t want to be on RFK’s bad side.
Other industry advocates figure they can at least slow Kennedy down enough to outlast him. There’s only so much he could do in four years, they believe.
“What they’re proposing to take on is at least a multi-year process,” Strom said.